AV
Alexandria Venture
Corporate VCActiveAlexandria Venture Investments is a strategic venture capital arm of Alexandria Real Estate Equities.
39
Investments
6
Exits
$500M
AUM
15.4%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Alexandria Venture.
Investment Thesis & Strategy
Alexandria Venture Investments, as a CVC, invests in various stages of real estate companies, seeking to strategically align with its parent company's focus. They likely look for innovative companies that can enhance or complement Alexandria Real Estate Equities' existing portfolio.
Investment Activity
Deals per year over the last 5 years
3
20173
20184
20191
20201
2021Portfolio Companies
Selected investments from their portfolio of 39 companies
T
Tessera Therapeutics
Biotech · Series B, 2021
G
Generate Biomedicines
Biotech · Series B, 2020
S
Sana Biotechnology
Biotech · Series B, 2019
A
Avalo Therapeutics
Biotech · Series B, 2019
S
Seer
Biotech · Series C+, 2019
L
Lyell Immunopharma
Biotech · Series B, 2019
B
Beam Therapeutics
Biotech · Series B, 2018
V
Vaxcyte
Biotech · Series B, 2018
A
AlloVir
Biotech · Series B, 2018
P
Pliant Therapeutics
Biotech · Series B, 2017
C
Cabaletta Bio
Biotech · Series A, 2017
G
Gossamer Bio
Biotech · Series A, 2017
Notable Exits
CompanyTypeYearValue / Acquirer
Obsidian TherapeuticsAcquisition2024—
Turning Point TherapeuticsAcquisition2022$4.1B
Ventyx BiosciencesIPO2022—
Revolution MedicinesIPO2020—
Zentalis PharmaceuticalsIPO2020—
Kura OncologyIPO2015—
Frequently Asked Questions
Alexandria Venture focuses on Series A, Series B stage investments.
Related Investors
Salesforce Ventures
San Francisco, United States · 463 deals
Cisco Investments
San Francisco, United States · 123 deals
Coinbase Ventures
San Francisco, United States · 39 deals
Workday Ventures
San Francisco, United States · 37 deals
Slack
San Francisco, United States · 29 deals
SAP.iO
San Francisco, United States · 29 deals